|
Characteristics
|
Number of cases (%)
|
SLP-2 expression (%)
|
P value
|
|---|
|
Low or no expression
|
High expression
| |
|---|
|
Age (years)
| | | |
0.433
|
|
<45
|
49 (35)
|
11 (22.4)
|
38 (77.6)
| |
|
≥45
|
91 (65)
|
26 (29.7)
|
65 (70.3)
| |
|
CA125 level (before surgery)
| | | |
0.067
|
|
<500U/ml
|
67 (47.9)
|
23 (34.3)
|
44 (65.7)
| |
|
≥500U/ml
|
73 (52.1)
|
15 (20.5)
|
58 (79.5)
| |
|
Tumour size
| | | |
0.501
|
|
<10 cm
|
58 (41.4)
|
14 (24.1)
|
44 (75.8)
| |
|
≥10 cm
|
82 (58.6)
|
24 (29.3)
|
58 (70.7)
| |
|
The volume of ascites
| | | |
0.014
|
|
<1000 ml
|
100 (71.4)
|
33 (33.0)
|
67 (67.0)
| |
|
≥1000 ml
|
40 (28.6)
|
5 (12.5)
|
35 (87.5)
| |
|
Peritoneal cytology
| | | |
0.001
|
|
Positive
|
68 (48.6)
|
10 (14.7)
|
58 (85.3)
| |
|
Negative
|
72 (51.4)
|
28 (38.9)
|
44 (61.1)
| |
|
Pathological type
| | | |
0.064
|
|
Serous
|
80 (57.1)
|
20 (25.0)
|
60 (75.0)
| |
|
Mucinous
|
14 (10.0)
|
8 (57.1)
|
6 (42.9)
| |
|
Poorly differentiated
|
36 (25.7)
|
8 (22.2)
|
28 (77.8)
| |
|
Othersa
|
10 (7.1)
|
2 (20.0)
|
8 (80.0)
| |
|
Grade of differentiation
| | | |
0.072
|
|
G1
|
59 (42.1)
|
11 (18.6)
|
48 (81.4)
| |
|
G2
|
46 (32.9)
|
13 (28.3)
|
33 (71.7)
| |
|
G3
|
18 (12.9)
|
9 (50.0)
|
9 (50.0)
| |
|
Unknown
|
17 (12.1)
|
5 (29.4)
|
12 (70.6)
| |
|
FIGO stage
| | | |
0.001
|
|
I
|
30 (21.4)
|
17 (56.7)
|
13 (43.3)
| |
|
II+ III + IV
|
110 (78.6)
|
21 (19.1)
|
89 (88.9)
| |
|
Lymph node metastasis
| | | |
0.688
|
|
Positive
|
21 (15.0)
|
7 (33.3)
|
14 (66.7)
| |
|
Negative
|
23 (16.4)
|
5 (21.7)
|
18 (78.3)
| |
|
Not do RPLNDb
|
96 (68.6)
|
26 (27.1)
|
70 (72.9)
| |
|
Cytoreductive surgeryc
| | | |
0.185
|
|
Optimal
|
107 (76.4)
|
32 (29.9)
|
75 (70.1)
| |
|
Suboptimal
|
33 (23.6)
|
6 (18.2)
|
27 (81.8)
| |
- aEndometrioid adenocarcinoma, two cases; clear cell carcinoma, three cases; mixed epithelial carcinoma, five cases
- bRPLND, retroperitoneal lymph node dissection, including unilateral or bilateral pelvic lymphadenectomy and /or paraortic lymphadenectomy
- cCytoreductive surgery: Optimal, the diameter of the largest residual lesions was < 2 cm;Suboptimal, the diameter of the largest residual lesions was ≥ 2 cm
